Published in Proc Natl Acad Sci U S A on May 01, 1992
Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J (1998) 3.12
Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet (2003) 2.52
Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol (1997) 2.40
Li-Fraumeni syndrome--a molecular and clinical review. Br J Cancer (1997) 2.14
Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet (1995) 1.46
Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest (1995) 1.43
Inherited predisposition to glioma. Neuro Oncol (2009) 0.99
Synchronous multifocal osteosarcoma: case report and literature review. Sarcoma (2006) 0.96
Seeding of osteosarcoma in the biopsy tract of a patient with multifocal osteosarcoma. Pediatr Radiol (2005) 0.93
Cancer risks from germline p53 mutations. J Clin Invest (1992) 0.89
Absence of hereditary p53 mutations in 10 familial leukemia pedigrees. J Clin Invest (1992) 0.85
Fibroblastic variant of osteosarcoma: a challenge in diagnosis & management. Open Dent J (2010) 0.77
Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma. Curr Oncol (2015) 0.75
p53 mutations in human cancers. Science (1991) 31.96
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics (1989) 19.10
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Mutations in the p53 gene occur in diverse human tumour types. Nature (1989) 13.62
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (1991) 7.49
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res (1990) 5.70
Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A (1987) 4.21
Structural aspects of the p53 protein in relation to gene evolution. Oncogene (1990) 3.64
Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med (1989) 3.03
High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol (1989) 2.45
Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction. Am J Pathol (1990) 2.18
Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci U S A (1990) 2.03
Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma. Proc Natl Acad Sci U S A (1975) 1.92
Genetics of cancer predisposition. Cancer Res (1987) 1.78
Prospective study of a family cancer syndrome. JAMA (1982) 1.69
Osteosarcomatosis. Radiology (1990) 1.62
Characterization of deletions at the retinoblastoma locus in patients with bilateral retinoblastoma. Am J Med Genet (1991) 1.59
Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res (1990) 1.33
Multifocal osteosarcoma: a case report with review of the literature. Cancer (1979) 1.32
Polymorphism at codon 213 within the p53 gene. Oncogene (1991) 1.30
Summary: multiple primary cancers in Connecticut, 1935-82. Natl Cancer Inst Monogr (1985) 1.20
Multiple metachronous osteogenic sarcoma. Report of twelve cases with two long-term survivors. J Bone Joint Surg Am (1973) 1.07
Childhood multifocal osteosarcoma. Clinicopathologic and radiologic correlates. Cancer (1985) 0.98
Molecular biology of neuroblastoma. J Clin Oncol (1999) 6.54
The International Neuroblastoma Pathology Classification (the Shimada system). Cancer (1999) 6.42
A rapid method for detecting and mapping homology between heterologous DNAs. Evaluation of polyomavirus genomes. J Biol Chem (1979) 5.32
Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation. Cell (1984) 5.05
Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization. J Virol (1979) 3.90
Beta 2-microglobulin expression in human embryonal neuroblastoma reflects its developmental regulation. Cancer Res (1990) 3.75
Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature (1985) 3.50
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol (1999) 3.35
Cloning of human papilloma virus genomic DNAs and analysis of homologous polynucleotide sequences. J Virol (1980) 3.34
Molecular cloning of polyoma virus DNA in Escherichia coli: lambda phage vector system. Science (1979) 3.17
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol (2005) 2.97
The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev (1994) 2.47
Characterization of polyoma viral DNA sequences in polyoma-induced hamster tumor cell lines. J Biol Chem (1980) 2.33
Chromosome translocation in peripheral neuroepithelioma. N Engl J Med (1984) 2.22
Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet (1986) 2.04
Tyrosine phosphorylation within the amino-terminal domain of pp60c-src molecules associated with polyoma virus middle-sized tumor antigen. Proc Natl Acad Sci U S A (1985) 1.96
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol (1996) 1.94
Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer (1997) 1.94
Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res (1995) 1.92
Molecular markers of neuroendocrine development and evidence of environmental regulation. Proc Natl Acad Sci U S A (1987) 1.84
Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol Cell Biol (1996) 1.81
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene (1999) 1.79
Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology (2000) 1.76
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. J Clin Oncol (2000) 1.74
Molecular cloning of polyoma virus DNA in Escherichia coli: plasmid vector system. Science (1979) 1.74
Middle tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with pp60c-src. J Virol (1985) 1.71
Biological activity of polyoma viral DNA in mice and hamsters. J Virol (1979) 1.70
Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem (1986) 1.67
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer (1997) 1.63
Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res (2001) 1.59
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer (2001) 1.58
Inhibition of apoptosis by the retinoblastoma gene product. EMBO J (1995) 1.58
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study. Med Pediatr Oncol (2001) 1.58
A human Id-like helix-loop-helix protein expressed during early development. Proc Natl Acad Sci U S A (1992) 1.53
Increased pp60c-src tyrosyl kinase activity in human neuroblastomas is associated with amino-terminal tyrosine phosphorylation of the src gene product. Proc Natl Acad Sci U S A (1985) 1.52
Cloned human polyomavirus JC DNA can transform human amnion cells. J Virol (1980) 1.50
Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res (1987) 1.49
Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad Sci U S A (1999) 1.47
Interrupting the early region of polyoma virus DNA enhances tumorigenicity. Proc Natl Acad Sci U S A (1979) 1.45
Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol (1997) 1.44
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol (2000) 1.44
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol (1995) 1.42
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. J Clin Oncol (2000) 1.42
Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol Res (1991) 1.41
Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest (1989) 1.41
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol (2000) 1.40
The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest (1997) 1.39
ENC-1: a novel mammalian kelch-related gene specifically expressed in the nervous system encodes an actin-binding protein. J Neurosci (1997) 1.37
Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet Cytogenet (1995) 1.35
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study. J Clin Oncol (2000) 1.33
Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol (1999) 1.33
The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer (1997) 1.30
Id-2 regulates critical aspects of human cytotrophoblast differentiation, invasion and migration. Development (2000) 1.26
Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer (1988) 1.25
Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res (1988) 1.24
Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay. Infect Immun (1981) 1.24
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim Biophys Acta (1992) 1.22
Effect of prenatal iron deficiency on myelination in rat pups. Am J Pathol (1986) 1.21
EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2001) 1.21
Comparison of constitutional and tumor-associated 11;22 translocations: nonidentical breakpoints on chromosomes 11 and 22. Proc Natl Acad Sci U S A (1986) 1.16
Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer (2002) 1.16
Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. J Biol Chem (1988) 1.16
Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest (1987) 1.15
Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest (1991) 1.15
Molecular cloning and primary structure of human glial fibrillary acidic protein. Proc Natl Acad Sci U S A (1989) 1.14
p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. Int J Radiat Oncol Biol Phys (1996) 1.14
Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma. Cancer Res (1988) 1.13
Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma. Cancer Res (1992) 1.13
A novel POU homeodomain gene specifically expressed in cells of the developing mammalian nervous system. Nucleic Acids Res (1992) 1.12
Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol Cell Biol (1988) 1.11
Is there a role for retinoids to treat minimal residual disease in neuroblastoma? Br J Cancer (2000) 1.11
A repertoire of differentially expressed transcription factors that offers insight into mechanisms of human cytotrophoblast differentiation. Dev Genet (1999) 1.11
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer (2001) 1.10
Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol (2001) 1.10
In vitro association and phosphorylation of polyoma virus middle T antigen by cellular tyrosyl kinase activity. J Biol Chem (1984) 1.10
Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol (2001) 1.09
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br J Cancer (2012) 1.09
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma. Q J Nucl Med Mol Imaging (2008) 1.08
Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ (1990) 1.08
The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc Natl Acad Sci U S A (1995) 1.07
RTVP-1, a novel human gene with sequence similarity to genes of diverse species, is expressed in tumor cell lines of glial but not neuronal origin. Gene (1996) 1.07
Annexin II marks astrocytic brain tumors of high histologic grade. Oncol Res (1994) 1.06
Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG. J Nucl Med (2001) 1.06
Polyoma large tumor antigen is not required for tumorigenesis mediated by viral DNA. Proc Natl Acad Sci U S A (1980) 1.04
The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer. Cancer Res (1998) 1.04
Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy. Hum Gene Ther (2000) 1.04
A determinant of polyomavirus virulence enhances virus growth in cells of renal origin. J Virol (1985) 1.03
Biologic activity of oligomeric forms of SV40 DNA. Virology (1978) 1.02
Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia. Int J Radiat Oncol Biol Phys (1992) 1.02
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst (1995) 1.02
Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors. Mol Cell Biol (1998) 1.01
Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies. J Pediatr (2001) 1.00
The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression. Proc Natl Acad Sci U S A (1998) 1.00
Inhibition of polyoma virus middle T antigen-associated tyrosyl kinase activity by N-ethylmaleimide. J Biol Chem (1983) 1.00
Id genes in nervous system development. Histol Histopathol (2000) 1.00
Id4 expression induces apoptosis in astrocytic cultures and is down-regulated by activation of the cAMP-dependent signal transduction pathway. Exp Cell Res (1999) 0.99
Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res (1995) 0.99